Gastrointestinal Health

Patients with inflammatory bowel disease (IBD) are at a higher risk of developing nonalcoholic fatty liver disease (NAFLD), a recently-published study concluded.

Pharmacists can play an important role in preventing foodborne illness.

Frozen and fresh product fully restored the microbiota diversity among participants within 7 days after treatment.

All antibiotics are thought to increase the risk of Clostridium difficile diarrhea, but current evidence suggests that particular drug classes are much worse than others in increasing this risk

Listeria (Listeriosis) is a serious infection usually caused by eating food contaminated with the bacteria Listeria monocytogenes.

The Changing Landscape of Beta Blockers in Cirrhosis

A recently-published study in JAMA suggests that Clostridium difficile may be more effectively treated with vancomycin than its more commonly used counterpart metronidazole.

The Changing Landscape of Beta Blockers in Cirrhosis

Children born to mothers who took heartburn medication were more likely to visit the physician for asthma symptoms.

A few years ago, celiac disease was the popular gastrointestinal disorder. In the last year or so, though, irritable bowel syndrome has seemingly taken over.

In your pharmacy practice, you are actively trying to perform more comprehensive medication reviews and stress to patients the value of services you offer.

There are fewer micronutrient deficiencies among gastric bypass patients than previously indicated.

In gastroesophageal reflux disease, the reflux of stomach contents results in disruptive symptoms or complications.

Despite how common gastroesophageal reflux disease is among patients, there are a few unfounded beliefs surrounding its symptoms, severity, and treatment.

Irritable bowel syndrome is a chronic, functional, gastrointestinal disorder characterized by symptoms of abdominal pain associated with altered bowel habits.

Dexilant SoluTab is a delayed-release orally disintegrating tablet that treats heartburn associated with GERD.

The FDA today approved a new formulation of Takeda Pharmaceuticals' dexlansoprazole.

If patients come to the pharmacy with ailments like heartburn, stomach pain, and difficulty swallowing, they may have acid reflux or gastroesophageal reflux disease.

Because calcium citrate is not dependent on acid or pH for absorption, it may be the preferred calcium supplement for PPI users.

The best way to reduce health care spending is to teach patients how to optimize their health and slow the aging process.

Overall survival rate nearly doubles in patients who used aspirin post-diagnosis.

Gastroprotective agents may be needed in postmenopausal women taking bisphosphonates.

Pharmacists are positioned to educate and monitor older patients who are discharged on these medications.

Since patients with Barrett's esophagus seem to progress to cancerous stages faster than others, health care professionals might perceive that controlling acid reflux would prevent the transition.

Gastroesophageal reflux disease and atrial fibrillation are 2 of the most significant health concerns in the United States, and researchers suspect a link between them.

Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.

Implementing interdisciplinary care reduces anesthetic exposures and related costs for pediatric patients with complex respiratory and gastrointestinal disorders.

A recent study suggests that co-administering the muscle relaxant, baclofen, with the proton pump inhibitor (PPI), omeprazole, may be more effective than PPI monotherapy in reducing heartburn and regurgitation in patients with gastroesophageal reflux disease (GERD).

As a result of confusing sensations of breathlessness with asthma symptoms, overweight and obese children tend to report poorer asthma control and overuse rescue medications.

Patients with irritable bowel syndrome cannot block pain signals from the gut as easily as those without the gastrointestinal condition.